{
    "clinical_study": {
        "@rank": "62203", 
        "arm_group": [
            {
                "arm_group_label": "Active medical device", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Inactive medical device", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The overall aim of the study is to investigate the effect of a new, non-pharmacological\n      method that may alleviate the symptoms of narcolepsy and thereby lead to a reduction in the\n      use of medications with potentially serious side effects in patients with this disease."
        }, 
        "brief_title": "Narcolepsy - New Potential Treatment", 
        "condition": "Narcolepsy", 
        "condition_browse": {
            "mesh_term": "Narcolepsy"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent\n\n          -  Diagnosed with narcolepsy (diagnose code G47.4)\n\n          -  16 - 60 years of age\n\n          -  MSLT has shown hypersomnia (sleeping latency < 8 min) & 1 episode REM\n\n          -  HLA-type associated with increased occurrence of narcolepsy\n\n        Exclusion Criteria:\n\n          -  Reduced cognitive function\n\n          -  Other relevant organ disease (that could affect the study results or put the patient\n             at risk)\n\n          -  Ongoing bacterial infection in the nose\n\n          -  Comorbidity that can increase the risk of bleeding\n\n          -  Has received treatment with an implantable stimulator or other implantable product in\n             the head and / or in the neck\n\n          -  Known pronounced septal deviation\n\n          -  Known allergy to polyvinylchloride or medicinal liquid paraffin\n\n          -  Women not using adequate contraceptives\n\n          -  Participated in a clinical investigational drug trial within the previous 30 days"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077036", 
            "org_study_id": "nervus11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active medical device", 
                "intervention_name": "Kinetic Oscillation Stimulation Device", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Inactive medical device", 
                "intervention_name": "Kinetic Oscillation Stimulation Device in placebo mode", 
                "intervention_type": "Device"
            }
        ], 
        "lastchanged_date": "February 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden"
                }, 
                "name": "Karolinska University Hospital"
            }, 
            "investigator": {
                "last_name": "Lars Hyllienmark, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "overall_contact": {
            "email": "lars.hyllienmark@karolinska.se", 
            "last_name": "Lars Hyllienmark, MD, PhD", 
            "phone": "+46-8-517 729 79"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in ESS scale between baseline before treatment and at 15-21 days after treatment.", 
            "measure": "Change in scale Epworth Sleep Scale (ESS)", 
            "safety_issue": "No", 
            "time_frame": "15-21 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077036"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska University Hospital", 
            "investigator_full_name": "Lars Hyllienmark", 
            "investigator_title": "Associate professor, consultant in neurology and clinical neurophysiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Change in MSLT (mean sleep latency, number of sleep onset rapid eye movement (SOREM), and mean SOREM latency) between registration at baseline and 14 days after treatment.", 
            "measure": "Change in multiple sleep latency test (MSLT)", 
            "safety_issue": "No", 
            "time_frame": "14 days"
        }, 
        "source": "Karolinska University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Karolinska University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}